Related Experiment Video
Updated: Nov 28, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for
Alessandro Maloberti1,2, Michele Bombelli2,3, Rita Facchetti2
1Cardiology IV, 'A. De Gasperis' Department, Ospedale Niguarda Ca' Granda.
Insights
Diuretic-related hyperuricemia (high uric acid) poses a similar cardiovascular event and mortality risk as hyperuricemia without diuretic use. This finding is crucial for understanding cardiovascular health in patients taking diuretics.
Area of Science:
- Cardiology
- Nephrology
- Pharmacology
Background:
- Hyperuricemia is a known risk factor for cardiovascular events.
- The specific impact of diuretic-induced hyperuricemia on cardiovascular outcomes remains under-researched.
Purpose of the Study:
- To investigate the relationship between diuretic-related hyperuricemia and cardiovascular events.
- To compare the cardiovascular risk associated with hyperuricemia in patients using diuretics versus those not using them.
Main Methods:
- The URic acid Right for heArt Health (URRAH) study, a nationwide observational cohort study in Italy.
- 17,747 individuals were analyzed, with follow-up averaging 122.3 months.
- Patients were grouped by diuretic use and serum uric acid (SUA) levels (median 4.8 mg/dl); outcomes included all-cause death and cardiovascular events.
Main Results:
- 17.2% of participants used diuretics, and 58% of these had SUA above the median.
- In multivariate analysis, individuals with hyperuricemia and diuretic use showed a similar risk for cardiovascular events and death compared to a reference group with hyperuricemia but no diuretic use.
- No significant difference in risk was observed between the groups.
Conclusions:
- Diuretic-related hyperuricemia is associated with a comparable risk of cardiovascular events and all-cause mortality as hyperuricemia in non-users.
- These findings highlight the importance of monitoring uric acid levels in patients on diuretic therapy.
- Further research may inform management strategies for cardiovascular risk in this population.
Objective:
Although the relationship between hyperuricemia and cardiovascular events has been extensively examined, data on the role of diuretic-related hyperuricemia are still scanty. The present study was designed to collect information on the relationship between diuretic-related hyperuricemia and cardiovascular events.
Methods:
The URic acid Right for heArt Health (URRAH) study is a nationwide, multicentre, observational cohort study involving data on individuals recruited from all the Italy territory under the patronage of the Italian Society of Hypertension with an average follow-up period of 122.3 ± 66.9 months. Patients were classified into four groups according to the diuretic use (yes vs. no) and serum uric acid (SUA) levels (higher vs. lower than the median value of 4.8 mg/dl). All-cause death, cardiovascular deaths and first cardiovascular event were considered as outcomes.
Results:
Seventeen thousand, seven hundred and forty-seven individuals were included in the analysis. Mean age was 57.1 ± 15.2 years, men were 45.3% and SBP and DBP amounted to 144.1 ± 24.6 and 85.2 ± 13.2 mmHg. 17.2% of individuals take diuretics of whom 58% had SUA higher than median value. Patients with hyperuricemia without diuretic use served as reference group. In multivariate adjusted analysis (sex, age, SBP, BMI, glucose, total cholesterol, and glomerular filtration rate) individuals with hyperuricemia and diuretic use exhibit a similar risk for the three outcomes as compared with the reference group.
Conclusion:
Our study showed that diuretic-related hyperuricemia carry a similar risk of cardiovascular events and all-cause mortality when compared with individuals that present hyperuricemia in absence of diuretic therapy.
More Related Videos
10:02Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril
Published on: October 3, 2020
05:57Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Related Concept Videos
Antihypertensive Drugs: Action of Diuretics
Heart Failure Drugs: Diuretics
Heart Failure V: Medical Management
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Antihypertensive Drugs: Potassium-Sparing Diuretics
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...